MARZARO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.162
AS - Asia 5.817
EU - Europa 2.761
SA - Sud America 901
AF - Africa 861
Continente sconosciuto - Info sul continente non disponibili 140
OC - Oceania 61
Totale 19.703
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.647
SG - Singapore 1.819
CN - Cina 1.167
VN - Vietnam 890
IT - Italia 835
BR - Brasile 550
HK - Hong Kong 495
FI - Finlandia 227
FR - Francia 212
BD - Bangladesh 211
DE - Germania 196
IN - India 172
PL - Polonia 141
GB - Regno Unito 129
SE - Svezia 115
NL - Olanda 104
RU - Federazione Russa 97
CA - Canada 96
IQ - Iraq 96
AR - Argentina 81
JP - Giappone 79
TR - Turchia 63
ZA - Sudafrica 60
ID - Indonesia 55
MX - Messico 55
UA - Ucraina 54
AT - Austria 53
SA - Arabia Saudita 52
EC - Ecuador 48
ES - Italia 48
PK - Pakistan 48
PH - Filippine 46
CH - Svizzera 42
CO - Colombia 38
VE - Venezuela 38
IE - Irlanda 37
BJ - Benin 36
KR - Corea 36
NI - Nicaragua 33
TT - Trinidad e Tobago 33
JM - Giamaica 32
MY - Malesia 32
UZ - Uzbekistan 32
CI - Costa d'Avorio 31
IL - Israele 31
PY - Paraguay 31
AO - Angola 30
CZ - Repubblica Ceca 30
PA - Panama 30
TN - Tunisia 30
EG - Egitto 29
GR - Grecia 29
IR - Iran 28
MD - Moldavia 28
UY - Uruguay 28
JO - Giordania 27
AE - Emirati Arabi Uniti 26
AZ - Azerbaigian 26
GF - Guiana Francese 26
LY - Libia 26
PS - Palestinian Territory 26
RO - Romania 26
RS - Serbia 26
CR - Costa Rica 25
CV - Capo Verde 25
DZ - Algeria 25
LB - Libano 25
NP - Nepal 25
TH - Thailandia 25
GA - Gabon 24
KE - Kenya 24
PT - Portogallo 24
AL - Albania 23
ET - Etiopia 23
GE - Georgia 23
TJ - Tagikistan 23
BB - Barbados 22
BE - Belgio 22
HN - Honduras 22
KH - Cambogia 22
MA - Marocco 22
MN - Mongolia 22
MU - Mauritius 22
PE - Perù 22
BO - Bolivia 21
LA - Repubblica Popolare Democratica del Laos 21
MR - Mauritania 21
MW - Malawi 21
RW - Ruanda 21
TW - Taiwan 21
AM - Armenia 20
BF - Burkina Faso 20
DO - Repubblica Dominicana 20
LC - Santa Lucia 20
CD - Congo 19
CW - ???statistics.table.value.countryCode.CW??? 19
HU - Ungheria 19
KZ - Kazakistan 19
XK - ???statistics.table.value.countryCode.XK??? 19
YT - Mayotte 19
Totale 18.704
Salva come PNG Salva come JPEG
Città #
Ashburn 1.197
Singapore 1.104
San Jose 963
Fairfield 780
Ann Arbor 531
Woodbridge 506
Hong Kong 440
Houston 393
Chandler 374
Beijing 305
Wilmington 289
Cambridge 282
Seattle 258
Ho Chi Minh City 250
Santa Clara 218
Hanoi 212
Los Angeles 151
Boardman 143
Padova 133
Jacksonville 113
Helsinki 108
New York 108
Princeton 103
Lauterbourg 97
Munich 96
Des Moines 93
Bytom 86
Medford 77
San Diego 69
Dong Ket 67
Milan 61
Da Nang 58
Buffalo 55
Council Bluffs 54
Nanjing 54
São Paulo 53
Tokyo 51
Roxbury 49
Orem 46
Turku 46
Chicago 38
Vienna 37
Baghdad 36
Cotonou 35
Abidjan 31
Managua 31
Shenyang 31
Warsaw 31
Brooklyn 30
Guangzhou 30
Dallas 29
Dublin 29
Tashkent 29
London 28
Luanda 27
The Dalles 27
Washington 27
Baku 26
Panama City 26
Riyadh 25
Rome 25
Amman 24
Atlanta 24
Haiphong 24
Libreville 24
Stockholm 24
Frankfurt am Main 23
Hefei 23
Boston 22
Chennai 22
Dushanbe 22
Montevideo 22
Phnom Penh 22
Praia 22
Athens 21
Cape Town 21
Guayaquil 21
Kigali 21
L’Aquila 21
Nouakchott 21
San Francisco 21
Castries 20
Johannesburg 20
San José 20
Ulan Bator 20
Bridgetown 19
Hải Dương 19
Kingston 19
Montreal 19
Phoenix 19
Addis Ababa 18
Istanbul 18
Kampala 18
Kuala Lumpur 18
Lusaka 18
Nairobi 18
Ouagadougou 18
Rio de Janeiro 18
Shanghai 18
Vientiane 18
Totale 11.501
Salva come PNG Salva come JPEG
Nome #
A NEW PRODUCTION METHOD OF HIGH SPECIFIC ACTIVITY RADIONUCLIDES TOWARDS INNOVATIVE RADIOPHARMACEUTICALS: THE ISOLPHARM PROJECT 378
The ISOLPHARM project: ISOL-based production of radionuclides for medical applications 313
Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties 285
Preliminary Discovery of Small Molecule Inhibitors of Epidermal Growth Factor Receptor (EGFR) That Bind to the Extracellular Domain 281
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 280
Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment 273
Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors 269
Early Evaluation of Copper Radioisotope Production at ISOLPHARM 268
Oleocanthalic acid improves MASH features via a NOX1-dependent mechanism 258
Substituted quinazolinones as kinase inhibitors endowed with anti-fibrotic properties 246
Novel benzoquinoline derivatives via unpredicted condensation of ethyl propiolate and naphthylamines: Synthesis and topoisomerase inhibition activity 246
Progetto Isolpharm_Ag: produzione di 111Ag e progettazione di radiofarmaci a scopo terapeutico 243
Targeting kinases with anilinopyrimidines: Discovery of N-phenyl-N'-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily 242
A new access to quinazolines from simple anilines 239
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 235
New Vandetanib analogs: fused tricyclic quinazolines with antiangiogenic potential. 234
Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB) 233
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening 231
Autogrid-based clusterization of kinases: selection of representative conformations for docking purposes 229
Psoralen Derivatives as Inhibitors of NF-κB/DNA Interaction: Synthesis, Molecular Modeling, 3D-QSAR, and Biological Evaluation 227
A Novel Aza-Derivative Inhibits agr Quorum Sensing Signaling and Synergizes Methicillin-Resistant Staphylococcus aureus to Clindamycin 227
Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting 225
A microwave improvement in the synthesis of the quinazoline scaffold 224
The Importance of Descriptor-Based Clusterization in QSAR Models Development: Tyrosine Kinases Inhibitors as a Key Study 223
Benzoquinazoline derivatives as new agents affecting DNA processing. 222
Aged Garlic Extract (AGE) and Its Constituent S-Allyl-Cysteine (SAC) Inhibit the Expression of Pro-Inflammatory Genes Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein and the BNT162b2 Vaccine 220
Psoralenquinones as a Novel Class of Proteasome Inhibitors: Design, Synthesis and Biological Evaluation 219
Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma 219
Preliminary evaluation of the production of non-carrier added 111Ag as core of a therapeutic radiopharmaceutical in the framework of ISOLPHARM_Ag experiment 218
Development and Validation of Novel Z-360-Based Macromolecules for the Active Targeting of CCK2-R 217
A novel convenient synthesis of benzoquinazolines 217
SAM50, a side door to the mitochondria: The case of cytotoxic proteases 212
Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib 210
A novel phenolic derivative inhibits AHL-dependent Quorum Sensing signaling in Pseudomonas aeruginosa 209
Exploring Epidermal Growth Factor Receptor (EGFR) Inhibitor Features: The Role of Fused Dioxygenated Rings on the Quinazoline Scaffold 208
Toward novel sulphur-containing derivatives of tetraazacyclododecane: Synthesis, acid-base properties, spectroscopic characterization, DFT calculations, and cadmium(ii) complex formation in aqueous solution 208
Quinazoline-based kinase inhibitors: new synthetic approach and biological evaluation. 201
Discovery Of Biarylaminoquinazolines As Novel Tubulin Polymerization Inhibitors 200
Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity 196
Differential Effects of Angelicin Analogues on NF- κ B Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 189
Pyrroloquinolinone-based dual topoisomerase I/II inhibitor 188
Productionvof carrier-free copper radionuclides with the ISOLPHARM method for nuclear medicine 188
Furochinazoline come potenziali bioisosteri di furocumarine: sintesi e proprieta’ fotobiologiche 187
Development of a Novel Furocoumarin Derivative Inhibiting NF-kB Dependent Biological Functions: Design, Synthesis and Biological Effects 185
Photochemical and photobiological studies on furoquinazolines as new psoralen analogs 185
Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators 185
Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016) 182
Synthesis of novel psoralen derivatives as inhibitors of NF-kB dependent biological function 181
Targeting kinases with anilinopyrimidines: discovery of N-phenyl-N’-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of Type III receptor tyrosine kinase subfamily 180
Photobiological properties of 3-psoralenacetic acids 179
4-Anilinoquinazolines endowed with antiangiogenic activity 179
6-Arylpyrimidines as novel attractive scaffolds for ATP competitive KSP inhibition 177
Microwave-promoted mono-N-alkylation of aromatic amines in water: a new efficient and green method for an old and problematic reaction 176
Synthesis and evaluation of erlotinib analogues: exploiting ring closure 174
Psoralen derivatives as inhibitors of NF-κB/DNA interaction: the critical role of the furan ring 174
Known triterpenes and their derivatives as scaffolds for the development of new therapeutic agents for cancer 174
Quinazoline derivatives as potential anticancer agents: a patent review (2007 – 2010) 171
Synthesis and evaluation of tricyclic quinazoline derivatives as egfr inhibitors 170
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 170
Psoralen derivatives as NF-kB/DNA interaction inhibitors: structural insight into the binding mode 169
A novel approach to quinazolin-4(3H)-one via quinazoline oxidation: an improved synthesis of 4-anilinoquinazolines 169
Development of transdermal delivery systems for innovative clinical applications of cannabinoids 169
Assessing the interaction between hemoglobin and the receptor binding domain of SARS-CoV-2 spike protein through MARTINI coarse-grained molecular dynamics 168
Discovery of novel wtRET and V804MRET inhibitors: from hit to lead 167
Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 ‘cytokine storm’ 166
ETHOSOMAL GEL FORMULATIONS FOR THE TRANSDERMAL DELIVERY OF CANNABINOIDS 166
Biphenylaminoquinazolines as novel dual inhibitors of tyrosine kinases and tubulin polymerization: synthesis, SARs and anticancer properties 165
Sintesi e purificazione dei precursori di desossiCBD per formulazioni innovative per cannabinoidi 164
Synthesis of small molecule-based ligands for active targeting of CCK2R for the ISOLPHAR-Ag project 164
Photobiological properties of 3-psoralenacetic acids 164
Biphenyl tricyclic quinazoline compounds 163
Deformable Vesicles with Edge Activators for the Transdermal Delivery of Non-Psychoactive Cannabinoids 162
Furoquinazolines as furocoumarin analogs: can we improve solubility without impairing biological activity? 162
Sviluppo di sistemi per la veicolazione transdermica di cannabinoidi 162
Discovery of Novel Quinazolinone Based mTOR Inhibitors Endowed with Antifibrotic Properties 159
QSAR and 3D-QSAR Models in the Field of Tubulin Inhibitors as Anticancer Agents 157
From single to multi-target kinases inhibitors: using the old-age kinases inhibitors data to face the new-age 157
Synthesis and Biological Evaluation of Pyrazole-Pyrimidones as a New Class of Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) 156
Dual kinase targeting in leukemia 154
Chinazoline benzosostituite: sintesi convenzionale vs. sintesi assistita da microonde. 152
New benzoquinazoline derivatives as antitumor agents 151
VESICULAR TRANSDERMAL DELIVERY SYSTEMS FOR CANNABINOIDS 150
Effects of analogues of 4,6,4'-trymethylangelicin on erythroid differentiation and NF-kB activity. 148
FB-Qsar based developement of novel potent Tyrosine-Kinase Inhibitors 146
Lejeuneaceae (Marchantiophyta) from a species-rich taphocoenosis in Miocene Mexican amber, with a review of liverworts fossilised in amber 146
ISOLPHAR_Ag Project:: production and purification of silver ion beams for 111Ag production. 146
N-acyl-omega-aminoacid ethanolamides resembling anandamide structure: synthesis and biological evaluation. 145
The Moss Macromitrium Richardii (Orthotrichaceae) with Sporophyte and Calyptra Enclosed in Hymenaea Resin from the Dominican Republic 143
Structure-Based Drug Design and Combinatorial Chemistry in the Search of Antimitotic Agents 143
Multicomponent Assembly of the Kinesin Spindle Protein Inhibitor CPUYJ039 and Analogues as Antimitotic Agents 142
Synthesis and characterization of novel possible bifunctional chelators for Silver-111 in the ISOLPHARM_Ag project 141
Benzochinazoline: nuovo approccio sintetico 140
Inibitori multitirosinchinasi utili per le patologie correlate: modelli farmacoforici, composti identificati tramite questi modelli, metodi per la loro preparazione, la loro formulazione e il loro impiego terapeutico 140
Biological evaluation of psoralen derivatives as inhibitors of NF-kappa B/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression. 140
ISOLPHARM_Ag Project: from the production of the the radioisotope 111Ag to the design of a radiopharmaceutical 140
Proteolysis Targeting Chimeric Molecules: Tuning Molecular Strategies for a Clinically Sound Listening 139
Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia 136
Biodistribution Assessment of a Novel 68Ga-Labeled Radiopharmaceutical in a Cancer Overexpressing CCK2R Mouse Model: Conventional and Radiomics Methods for Analysis 136
The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells 135
sintesi e studio di polieterocicli azotati ad attività antitumorale 130
Totale 19.131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.516
article - articoli 39.348
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 780
selected - selezionate 0
volume - volumi 0
Totale 94.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.061 0 180 101 89 80 58 44 113 46 27 73 250
2022/2023920 179 64 17 97 148 140 10 77 100 16 47 25
2023/2024753 31 86 94 57 55 125 44 63 21 34 75 68
2024/20252.499 28 127 119 122 350 62 131 150 242 92 420 656
2025/202610.439 576 784 1.252 1.451 1.091 468 1.370 855 1.058 651 520 363
2026/2027446 417 29 0 0 0 0 0 0 0 0 0 0
Totale 19.703